[
  {
    "ts": null,
    "headline": "Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
    "summary": "The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth drivers include a rising need for precise diagnostic tools and a focus on enhanced patient outcomes. Innovations in diagnostic technologies and strategic partnerships among industry leaders are paving the way for improvements. Leading companies like Abbott Laboratories, Bio-Rad, Roche Diagnostics, and Siemens Healt",
    "url": "https://finnhub.io/api/news?id=0b34d0cd6b76a547bc91fe48f48af39275125705c9b5843feaf0f0c2168718ac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764000300,
      "headline": "Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
      "id": 137591474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth drivers include a rising need for precise diagnostic tools and a focus on enhanced patient outcomes. Innovations in diagnostic technologies and strategic partnerships among industry leaders are paving the way for improvements. Leading companies like Abbott Laboratories, Bio-Rad, Roche Diagnostics, and Siemens Healt",
      "url": "https://finnhub.io/api/news?id=0b34d0cd6b76a547bc91fe48f48af39275125705c9b5843feaf0f0c2168718ac"
    }
  },
  {
    "ts": null,
    "headline": "Booking, Carvana upgraded: Wall Street's top analyst calls",
    "summary": "Booking, Carvana upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=0f5f129f7c998980ac8af86edd2de703660b77cb241f70048c181d6e85e403a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763995260,
      "headline": "Booking, Carvana upgraded: Wall Street's top analyst calls",
      "id": 137591331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Booking, Carvana upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=0f5f129f7c998980ac8af86edd2de703660b77cb241f70048c181d6e85e403a7"
    }
  },
  {
    "ts": null,
    "headline": "Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
    "summary": "With its stock down 2.6% over the past three months, it is easy to disregard Abbott Laboratories (NYSE:ABT). But if you...",
    "url": "https://finnhub.io/api/news?id=885f298a3a020ac6fcbb49aec5e15a712c87b3409f09a18163f889c30e58db94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763982046,
      "headline": "Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
      "id": 137589201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "With its stock down 2.6% over the past three months, it is easy to disregard Abbott Laboratories (NYSE:ABT). But if you...",
      "url": "https://finnhub.io/api/news?id=885f298a3a020ac6fcbb49aec5e15a712c87b3409f09a18163f889c30e58db94"
    }
  }
]